Business
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform CapabilitiesANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'')
About this update from Endra Life Sciences Inc.
[{"type":"text","content":"Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform CapabilitiesANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has recently been issued Patents 10,682,059 and 10,687,789 from the United States Patent and Trademark Office.\"These patents represent a key step forward in the development and protection of our technology platform, which optimizes hybrid ultrasound and thermoacoustic imaging systems for a wide variety of clinical applications,\" explained ENDRA's Chief Executive Officer, Francois Michelon. \"While the two most recent patent grants are significant because they apply to our platform capabilities, they are supported and strengthened by the fact they are part of a growing IP portfolio, which currently stands at 72 assets, which cover other critical aspects of our technology.\"ENDRA's goal is to develop, patent and commercialize applications for our proprietary TAEUS technology in areas of high unmet clinical need, such as Non-Alcoholic Fatty Liver Disease (NAFLD) which affects over 1 billion people globally, and for which there are no practical diagnostic tools.The recently-issued ‘059 patent provides more robust intellectual property (IP) protection for our TAEUS platform related to our disruptive scanning approach. It covers a radio frequency (RF) applicator device and system for providing reliable RF energy to a target area of tissue. More particularly, the '059 patent structurally defines ENDRA's innovative solution to providing targeted RF energy to tissue regions for applications, such as fat quantification of a patient's liver.The recently-issued ‘789 patent provides more robust intellectual property (IP) protection for our TAEUS platform on the diagnostic and analysis side. It covers a method and system for reconstructing a thermoacoustic image. More particularly, the '789 patent utilizes a view and position specific kernel to correct for differences in the relative relationship between a transducer element array and an object within a region of interest to be imaged.About ENDRA Life Sciences Inc.ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology that visualizes tissue like CT or MRI, but at 50X lower cost, at the point of patient car...